Analyze Diet

Kinetics and pharmacology of estrogens in pre- and postmenopausal women.

Abstract: With the approach of the menopause and the cessation of ovarian estrogen production, a number of uncomfortable and/or dangerous conditions may be manifested, and are all indications for estrogen replacement therapy. Various routes of estrogen administration are available--oral, subcutaneous implant, intravaginal, and transdermal--each having advantages and disadvantages. There is also a choice possible among replacement hormones, which include the natural estrogens, such as estradiol and estropipate; synthetic estrogens, for example, ethinyl estradiol and diethylstilbestrol; and conjugated equine estrogens. Depending on both route of administration and choice of hormone, there are great differences demonstrable in kinetics and pharmacologic characteristics, which have not been reflected, however, by highly significant differences in clinical outcome so far.
Publication Date: 1993-01-01 PubMed ID: 8499960
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on the differences in kinetics and pharmacologic characteristics of estrogens given through various administration routes and choices of hormone in pre- and postmenopausal women and how it impacts their overall health and menopause symptoms.

Introduction

Estrogen plays a crucial role in a woman’s body, especially during the years leading up to and after menopause. With the cessation of estrogen production by the ovaries during menopause, women often experience uncomfortable and sometimes dangerous conditions, which can be managed with estrogen replacement therapy.

Methods of Estrogen Administration

  • The study elaborates on several ways to administer estrogen including oral consumption, subcutaneous implant, intravaginal application, and transdermal application. Each method has its own set of pros and cons.

Choice of Replacement Hormones

  • The research also investigates the variety of replacement hormones available. These include natural estrogens like estradiol and estropipate, synthetic estrogens such as ethinyl estradiol and diethylstilbestrol, and conjugated equine estrogens, which are derived from horse urine.

Differences in Kinetics and Pharmacology

  • The study notes significant differences in the kinetics (how the body processes the drug) and pharmacological characteristics (the drug’s effects and mechanism of action in the body) depending on the route of administration and the type of hormone administered. These differences could potentially influence the efficacy and side effects of the treatment.

Lack of Significant Differences in Clinical Outcomes

  • Despite these observable differences in kinetics and pharmacology, the research found that these variations have not produced significant differences in clinical outcomes for menopausal women so far. This implies that while certain methods of administration or specific hormones may result in different physiological responses, these differences may not necessarily translate into noticeable changes for the patient in terms of menopause symptom relief.

Cite This Article

APA
Anderson F. (1993). Kinetics and pharmacology of estrogens in pre- and postmenopausal women. Int J Fertil Menopausal Stud, 38 Suppl 1, 55-64.

Publication

ISSN: 1069-3130
NlmUniqueID: 9309760
Country: United States
Language: English
Volume: 38 Suppl 1
Pages: 55-64

Researcher Affiliations

Anderson, F
  • Product Development Center, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk.

MeSH Terms

  • Adult
  • Blood Pressure / drug effects
  • Estrogen Replacement Therapy
  • Estrogens / administration & dosage
  • Estrogens / pharmacokinetics
  • Estrogens / pharmacology
  • Female
  • Humans
  • Menopause / drug effects
  • Menopause / physiology
  • Metabolic Clearance Rate
  • Middle Aged
  • Ovary / metabolism

Citations

This article has been cited 1 times.
  1. Le Roux Y, Borg ML, Sibille M, Thebault J, Renoux A, Douin MJ, Djebbar F, Dain MP. Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System. Clin Drug Investig 1995 Sep;10(3):172-8.